export interface TechnicalBlogSection {
  heading: string;
  paragraphs: string[];
  points?: string[];
}

export interface TechnicalBlogArticle {
  slug: string;
  title: string;
  shortTitle: string;
  description: string;
  primaryKeyword: string;
  tag: string;
  readingTime: string;
  intro: string;
  painPoints: { title: string; detail: string }[];
  sections: TechnicalBlogSection[];
  caseStudy: {
    label: string;
    title: string;
    context: string;
    actions: string[];
    result: string;
  };
  checklist: string[];
  sources: { label: string; href: string }[];
  productLinks: { label: string; href: string }[];
}

export const EUROPE_HPLC_ARTICLES: TechnicalBlogArticle[] = [
  {
    slug: "hplc-solvents-europe-compliance-supply-guide",
    title: "HPLC Solvents in Europe: A Compliance-Ready Supply Plan for Laboratories",
    shortTitle: "HPLC Solvents in Europe: Compliance and Supply Guide",
    description: "A practical HPLC solvents Europe guide covering SDS languages, CLP labels, ADR transport, product qualification and receiving controls for European laboratories.",
    primaryKeyword: "HPLC solvents Europe",
    tag: "European Market",
    readingTime: "10 min technical guide",
    intro: "Buying a solvent that performs well in the chromatograph is only one part of supplying a European laboratory. The same shipment must arrive with usable safety information, compliant identification, traceable batch documents and packaging suitable for dangerous-goods transport. This guide turns those requirements into a practical purchasing and qualification workflow.",
    painPoints: [
      { title: "Documents arrive too late", detail: "Quality, EHS and customs teams cannot release a shipment when the SDS, batch COA or transport details are missing or inconsistent." },
      { title: "One English SDS is treated as universal", detail: "European destinations can require labels and safety data sheets in national languages, so market coverage must be planned before dispatch." },
      { title: "Grade labels hide performance risk", detail: "The words HPLC grade do not define the exact UV, water, residue or gradient limits needed by a laboratory method." },
      { title: "Packaging is qualified after purchase", detail: "Container compatibility, closure integrity and ADR handling are often checked only after a leakage, delay or receiving deviation." },
    ],
    sections: [
      {
        heading: "Start with the laboratory method, not the supplier catalogue",
        paragraphs: [
          "The useful starting point is a short user requirement specification. Record the detector type, lowest working wavelength, isocratic or gradient programme, expected sensitivity, maximum acceptable water content, non-volatile residue risk and typical daily consumption. A UV method at 254 nm may tolerate a different solvent profile from an impurity method operating close to the solvent cutoff, even when both use the same chemical name.",
          "European Pharmacopoeia general chapter 2.2.46 establishes harmonised concepts and system-suitability requirements for chromatographic procedures. It does not turn a generic grade name into a universal purchasing specification. The laboratory still needs acceptance criteria that connect the solvent to the intended procedure and its system-suitability limits.",
        ],
        points: [
          "Define assay, water, residue and UV requirements before requesting a quote.",
          "Add gradient suitability when the method changes organic composition during the run.",
          "For LC-MS use, add mass-spectrometry background and trace-metal expectations rather than assuming HPLC grade is sufficient.",
        ],
      },
      {
        heading: "Build a European document pack before the first shipment",
        paragraphs: [
          "ECHA explains that an SDS communicates properties, hazards, handling, disposal, transport, first aid, firefighting and exposure controls, and that its format and content are specified by REACH. The purchasing pack should therefore be checked as an operational document, not collected only as a formality. Product identity, supplier identity, classification, transport information and storage instructions should agree across the SDS, label, TDS and purchase order.",
          "Language planning is a separate task. ECHA publishes a country-by-country list of languages required for labels and safety data sheets. A distributor serving Germany, France and Belgium should not wait until the goods are at the border to decide which controlled translations are needed. The document matrix should be linked to the destination, customer role and planned resale route.",
        ],
        points: [
          "TDS and product specification for technical qualification.",
          "Current SDS in the destination language where required.",
          "Representative COA for initial review and batch-specific COA for delivery.",
          "CLP-ready label data and ADR transport classification for hazardous solvents.",
        ],
      },
      {
        heading: "Treat packaging and logistics as part of analytical quality",
        paragraphs: [
          "ECHA states that hazardous-chemical packaging must prevent unintended escape and remain resistant to its contents. For the laboratory, the analytical question goes further: can the package protect the qualified solvent until the last withdrawal? Closure materials, headspace, repeated opening and transfer practices can change water uptake, particulate load or extractables.",
          "ADR 2025 provides the current European framework for international road transport of dangerous goods. Buyers do not need to reproduce the ADR text in a solvent specification, but they should require the correct UN reference, packaging group where applicable, compatible container and shipping documentation. A 1 L qualification bottle and a 200 L production drum should be evaluated as different handling systems even if the chemical specification is the same.",
        ],
      },
      {
        heading: "Create a receiving control that does not duplicate the supplier",
        paragraphs: [
          "A practical incoming check confirms identity, batch number, seal condition, document match and storage requirement. It then applies risk-based testing appropriate to the method and supplier history. The objective is not to repeat every release test on every container; it is to detect mismatches before the solvent enters a validated workflow.",
          "Trend complaints, chromatographic anomalies, damaged closures and document corrections by batch and by packaging format. This history provides the evidence needed to reduce controls for a stable supply relationship or increase them after a meaningful change.",
        ],
      },
    ],
    caseStudy: {
      label: "Application scenario",
      title: "A multi-country contract laboratory standardises solvent approval",
      context: "An illustrative European contract laboratory receives HPLC solvents at one central warehouse and distributes them to sites using different national languages and different detector wavelengths. The recurring problem is not a failed assay; it is inconsistent documentation and site-by-site requalification.",
      actions: [
        "The technical team creates one core solvent specification with method-specific addenda for low-wavelength and gradient applications.",
        "EHS maps the required SDS and label languages to each receiving country before purchase approval.",
        "Logistics qualifies bottle and drum formats separately and records the ADR data required for internal distribution.",
        "Each site uses the same receiving checklist and links the delivered batch COA to the local inventory record.",
      ],
      result: "The result is a single qualification framework with controlled local-market documents. This is an implementation pattern, not a claim about a named customer or guaranteed regulatory outcome.",
    },
    checklist: [
      "Method-linked solvent specification approved by the laboratory owner",
      "TDS, reference specification and representative COA reviewed before qualification",
      "Destination-language SDS and label requirements mapped",
      "CLP identity and hazard information checked across documents",
      "ADR classification and packaging format confirmed before shipment",
      "Batch-specific COA and seal condition checked at receipt",
      "Change notification and complaint escalation route agreed",
    ],
    sources: [
      { label: "ECHA - Safety data sheets", href: "https://echa.europa.eu/safety-data-sheets" },
      { label: "ECHA - Labelling and packaging under CLP", href: "https://echa.europa.eu/web/guest/regulations/clp/labelling" },
      { label: "ECHA - Languages required for labels and SDS", href: "https://echa.europa.eu/documents/10162/17217/languages_required_for_labels_and_sds_en.pdf" },
      { label: "UNECE - ADR 2025", href: "https://unece.org/info/Transport/Dangerous-Goods/pub/395786" },
      { label: "EDQM - Ph. Eur. chapter 2.2.46", href: "https://www.edqm.eu/en/w/general-chapter-2.2.46.-chromatographic-separation-techniques-now-published-in-ph.-eur.-11th-edition" },
    ],
    productLinks: [
      { label: "Browse HPLC Grade Solvents", href: "/products/high-purity-solvents/hplc-grade-solvents" },
      { label: "Open Product Document Library", href: "/downloads" },
    ],
  },
  {
    slug: "hplc-grade-acetonitrile-europe-supply-continuity",
    title: "HPLC Grade Acetonitrile in Europe: A Dual-Supply Qualification Strategy",
    shortTitle: "HPLC Grade Acetonitrile Europe: Dual-Supply Strategy",
    description: "How European laboratories can qualify HPLC grade acetonitrile for supply continuity without losing gradient performance, traceability or method control.",
    primaryKeyword: "HPLC grade acetonitrile Europe",
    tag: "Supply Continuity",
    readingTime: "9 min technical guide",
    intro: "Acetonitrile is central to many reversed-phase methods, yet laboratories often discover that their continuity plan is only a list of alternative suppliers. A defensible second-source plan must show that the alternative solvent is suitable for the actual method, package and quality system before the preferred source becomes unavailable.",
    painPoints: [
      { title: "Emergency qualification", detail: "A second source is tested only after stock is already critical, forcing rushed technical and quality decisions." },
      { title: "Assay is used as the only comparison", detail: "Two lots can meet a purity claim while behaving differently in low-UV gradients or sensitive impurity methods." },
      { title: "Packaging changes with the supplier", detail: "A move from bottles to drums changes transfer, water exposure and contamination risks." },
      { title: "No change-control trigger", detail: "Laboratories do not define when a new manufacturing site, closure or test method requires partial requalification." },
    ],
    sections: [
      {
        heading: "Define equivalence at the method level",
        paragraphs: [
          "A dual-source programme should begin with the registered or controlled analytical procedure. Identify the performance characteristics most likely to be affected by solvent quality: baseline noise, gradient drift, ghost peaks, retention time, peak area precision, resolution and sensitivity. The acceptance criteria should come from the method's established system-suitability and analytical control strategy, not from a generic expectation that all HPLC grades are interchangeable.",
          "EMA's ICH Q14 guidance describes science- and risk-based development and maintenance of analytical procedures, including robustness and lifecycle management. That framework supports a focused solvent comparison: challenge the factors that matter, document the knowledge gained and predefine what constitutes an acceptable supplier change.",
        ],
      },
      {
        heading: "Use a three-layer acetonitrile comparison",
        paragraphs: [
          "The first layer is document equivalence. Compare identity, assay, water, acidity or alkalinity, residue after evaporation, UV absorbance profile, gradient test, trace metals where relevant, manufacturing site, packaging and shelf life. Record differences rather than forcing unlike specifications into a single yes-or-no column.",
          "The second layer is laboratory screening. Run neat-solvent UV scans where useful, blank injections, the full gradient without sample and a system-suitability solution. The third layer is method confirmation using representative samples around the reporting threshold. Each layer has a separate purpose: document risk, detect obvious incompatibility and confirm method performance.",
        ],
        points: [
          "Test both suppliers in the intended bottle or bulk-transfer format.",
          "Include at least one lot from each source; add more lots when the method has a narrow operating window.",
          "Use the same instrument state, column lot, mobile-phase additives and sequence design.",
          "Retain chromatograms and raw data with the approval record.",
        ],
      },
      {
        heading: "Plan stock policy around qualification lead time",
        paragraphs: [
          "Continuity is a timing problem as much as a supplier problem. Estimate the time needed for sample delivery, document review, analytical comparison, quality approval and import transport. The reorder point should protect that complete period, not only the supplier's quoted production lead time.",
          "For European delivery, confirm the applicable SDS language, CLP label information and dangerous-goods documentation before the first commercial shipment. A technically acceptable solvent is not an operational second source if it cannot be received and released at the destination site.",
        ],
      },
      {
        heading: "Convert the study into a maintained control strategy",
        paragraphs: [
          "Approval should specify which sites, grades, packages and methods are covered. A bottle study should not silently approve an IBC transfer system. Define triggers for review, including manufacturing-site changes, specification changes, analytical-method changes, container or closure changes, repeated document errors and unexpected chromatographic trends.",
          "Keep a small retained sample or reference chromatogram where internal procedures allow. The goal is fast, evidence-based triage when a future lot produces an anomaly, not the assumption that every deviation originates with the solvent.",
        ],
      },
    ],
    caseStudy: {
      label: "Qualification case framework",
      title: "A European generics QC laboratory prepares a second source",
      context: "An illustrative QC laboratory uses acetonitrile in several release methods, including one demanding gradient impurity method. The laboratory wants continuity without repeating a full study for every routine assay.",
      actions: [
        "Methods are ranked by solvent sensitivity; the gradient impurity method becomes the worst-case technical challenge.",
        "The team compares supplier documents and tests blanks, system suitability and representative samples using the same controlled sequence.",
        "Lower-risk isocratic methods are bridged only after the worst-case method passes predefined criteria.",
        "Approval is limited to the tested bottle format, with a separate plan for future drum supply.",
      ],
      result: "The case produces a reusable decision tree and a qualified backup source without claiming that one study automatically covers every method or package.",
    },
    checklist: [
      "Worst-case acetonitrile method identified",
      "Supplier specifications and sample COAs compared",
      "Blank, gradient and system-suitability sequence approved",
      "Package format included in the qualification scope",
      "SDS, CLP and transport documents ready for the destination",
      "Reorder point includes technical and quality approval time",
      "Change-control and requalification triggers documented",
    ],
    sources: [
      { label: "EMA - ICH Q14 analytical procedure development", href: "https://www.ema.europa.eu/en/ich-q14-analytical-procedure-development-scientific-guideline" },
      { label: "EMA - ICH Q2(R2) analytical procedure validation", href: "https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline" },
      { label: "European Commission - EU GMP Chapter 6 Quality Control", href: "https://health.ec.europa.eu/document/download/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf" },
      { label: "EDQM - Chromatographic separation techniques", href: "https://www.edqm.eu/en/w/general-chapter-2.2.46.-chromatographic-separation-techniques-now-published-in-ph.-eur.-11th-edition" },
    ],
    productLinks: [
      { label: "View Acetonitrile", href: "/products/hplc-grade-solvents/acetonitrile" },
      { label: "Browse Gradient Grade Solvents", href: "/products/high-purity-solvents/gradient-grade-solvents" },
    ],
  },
  {
    slug: "hplc-grade-methanol-europe-gradient-baseline",
    title: "HPLC Grade Methanol in Europe: Solving Gradient Baseline and Ghost-Peak Problems",
    shortTitle: "HPLC Grade Methanol Europe: Gradient Baseline Guide",
    description: "A troubleshooting and qualification guide for HPLC grade methanol in Europe, focused on gradient baseline drift, ghost peaks, water uptake and packaging control.",
    primaryKeyword: "HPLC grade methanol Europe",
    tag: "Troubleshooting",
    readingTime: "10 min technical guide",
    intro: "When a gradient baseline rises or an unexpected peak appears, the solvent is an easy suspect but rarely the only possible cause. A structured investigation separates methanol-lot effects from mobile-phase additives, water, reservoirs, tubing, columns and instrument carryover, while preserving the evidence needed for a supplier discussion.",
    painPoints: [
      { title: "Every blank looks different", detail: "The laboratory compares solvents under different instrument conditions and cannot determine whether the lot or the system changed." },
      { title: "Water uptake is invisible", detail: "Repeated opening and poorly controlled dispensing alter the composition before a solvent reaches the mobile phase." },
      { title: "Ghost peaks appear late in the gradient", detail: "Contaminants can concentrate at the column head and elute only at stronger mobile-phase composition." },
      { title: "The complaint lacks evidence", detail: "A supplier receives a chromatogram without sequence conditions, batch number, additive details or a control solvent comparison." },
    ],
    sections: [
      {
        heading: "Separate system background from solvent background",
        paragraphs: [
          "Begin with a controlled blank ladder: instrument or seal-wash blank where applicable, water blank, methanol blank, prepared mobile phase without column, mobile phase with column and the full method blank. Change one factor at a time. A direct comparison is useful only when the instrument state, column, tubing, vials, additives, gradient programme and detection settings are held constant.",
          "The European Pharmacopoeia chromatography chapter places system suitability inside the analytical procedure. That principle matters during troubleshooting: a solvent investigation should use the same critical performance measures that decide whether the method is fit to run, rather than a visual judgement of one chromatogram alone.",
        ],
      },
      {
        heading: "Read gradient drift as a concentration experiment",
        paragraphs: [
          "In a gradient, increasing organic strength can sweep retained contamination from the column, mixer, tubing or mobile-phase reservoir. A peak that is absent during direct injection may still emerge in the full gradient. Run the complete blank programme and note whether the feature follows time, composition, column exposure or injection count.",
          "Compare UV absorbance at method-relevant wavelengths and review the supplier's gradient test when available. Low assay variation does not rule out a trace UV-active impurity. For low-wavelength methods, the useful specification is the absorbance profile and baseline response close to the operating wavelength, not only a single purity number.",
        ],
        points: [
          "Use freshly prepared mobile phase from controlled water and additives.",
          "Bracket the suspect methanol lot with an approved control lot in the same sequence.",
          "Record column conditioning and blank history before interpreting late-eluting peaks.",
          "Review whether the peak area grows with repeated blank injections, indicating accumulation or carryover.",
        ],
      },
      {
        heading: "Control water and packaging after opening",
        paragraphs: [
          "Methanol is hygroscopic, so the qualified state includes the way the container is handled. Define an open-container period, dispensing practice and storage location based on method sensitivity and internal stability evidence. Large packs reduce packaging waste but can increase repeated-opening and transfer risk when the laboratory has no closed dispensing system.",
          "A useful packaging decision compares daily use, time open, headspace exposure, transfer equipment and disposal. One consolidated TDS may list every pack size, but the laboratory should select the pack that can be consumed within its controlled handling window.",
        ],
      },
      {
        heading: "Write a supplier complaint that can be investigated",
        paragraphs: [
          "Provide product name, grade, batch, package, opening date, storage history, chromatographic method, detector wavelength, gradient, additive, water source, column information, system history and comparative data from an approved lot. Retain the suspect container and an uncontaminated sample if possible.",
          "EU GMP Chapter 6 calls for special attention to the quality of laboratory reagents and solutions, with control commensurate to use and stability data. A complete deviation record supports that expectation and gives both laboratory and supplier a reproducible starting point.",
        ],
      },
    ],
    caseStudy: {
      label: "Troubleshooting scenario",
      title: "A late gradient peak appears after a methanol lot change",
      context: "An illustrative laboratory observes a new peak near the strong-organic end of an impurity method after changing methanol lot. The initial assumption is solvent contamination, but the sequence also followed column maintenance.",
      actions: [
        "The team reconstructs the timeline and runs suspect and control methanol in one bracketed sequence.",
        "It includes full gradient blanks with and without the analytical column and holds water, additives and vials constant.",
        "The laboratory records whether the peak follows the methanol lot, the column or the number of gradient cycles.",
        "Only after the factor is isolated does it open a supplier investigation or an internal equipment deviation.",
      ],
      result: "The framework prevents an unsupported supplier conclusion and produces data that can support corrective action regardless of the final source.",
    },
    checklist: [
      "Suspect and approved methanol lots tested in the same sequence",
      "Water, additives, vials and mobile-phase preparation held constant",
      "Blank ladder distinguishes instrument, column and solvent contributions",
      "Full gradient reviewed, not only a neat-solvent injection",
      "Open-container age and storage history documented",
      "Batch COA and method-relevant UV or gradient data reviewed",
      "Complaint package contains reproducible conditions and comparison data",
    ],
    sources: [
      { label: "EDQM - Ph. Eur. chapter 2.2.46", href: "https://www.edqm.eu/en/w/general-chapter-2.2.46.-chromatographic-separation-techniques-now-published-in-ph.-eur.-11th-edition" },
      { label: "EDQM - Signal-to-noise revision for chapter 2.2.46", href: "https://www.edqm.eu/en/-/signal-to-noise-ratio-revision-of-ph.-eur.-general-chapter-chromatographic-separation-techniques-2.2.46-" },
      { label: "European Commission - EU GMP Chapter 6 Quality Control", href: "https://health.ec.europa.eu/document/download/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf" },
      { label: "EMA - ICH Q2(R2)", href: "https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline" },
    ],
    productLinks: [
      { label: "View Methanol", href: "/products/hplc-grade-solvents/methanol" },
      { label: "Browse HPLC Grade Solvents", href: "/products/high-purity-solvents/hplc-grade-solvents" },
    ],
  },
  {
    slug: "hplc-solvent-supplier-qualification-eu-gmp",
    title: "HPLC Solvent Supplier Qualification for EU GMP Laboratories",
    shortTitle: "HPLC Solvent Supplier Qualification for EU GMP Labs",
    description: "A risk-based HPLC solvent supplier qualification framework for EU GMP laboratories, including documents, sample testing, change control and ongoing review.",
    primaryKeyword: "HPLC solvent supplier qualification",
    tag: "EU GMP",
    readingTime: "11 min technical guide",
    intro: "A supplier questionnaire alone does not demonstrate that a solvent is suitable for a controlled analytical procedure. Qualification works when quality-system evidence, product documentation, representative samples, method performance and lifecycle controls are connected in one risk-based file.",
    painPoints: [
      { title: "The audit file and laboratory file are disconnected", detail: "Quality reviews the company while analysts test the product, but nobody reconciles the two conclusions." },
      { title: "Representative data is mistaken for batch release data", detail: "A sample COA supports initial review but cannot replace the COA for the delivered lot." },
      { title: "Critical changes arrive through sales email", detail: "Site, process, specification and packaging changes do not enter formal change control." },
      { title: "Annual review is only a document expiry check", detail: "Complaints, deviations, chromatographic trends and delivery performance are not assessed together." },
    ],
    sections: [
      {
        heading: "Set the qualification depth from analytical risk",
        paragraphs: [
          "Rank the solvent by its effect on patient-relevant or release decisions, method sensitivity, detectability of failure, supply complexity and volume. A solvent used only for equipment rinsing does not need the same technical evidence as a mobile-phase solvent used in a low-level impurity method. Document the rationale so that the approval route is proportionate and repeatable.",
          "EU GMP Chapter 6 states that special attention should be given to the quality of laboratory reagents and solutions and that controls should be commensurate with their use and available stability data. That provides a practical anchor for solvent qualification: define what the solvent does in the method, then scale the control accordingly.",
        ],
      },
      {
        heading: "Build one file with four evidence layers",
        paragraphs: [
          "Company evidence covers legal identity, manufacturing and testing sites, quality-system certifications, complaint handling, traceability and business continuity. Product evidence covers specification, TDS, SDS, representative COA, manufacturing route at an appropriate level, packaging and shelf life. Laboratory evidence covers sample evaluation in the intended or worst-case method. Supply evidence covers lead time, dangerous-goods capability, language documents and batch-document delivery.",
          "Each layer should end with a decision, owner and open actions. A large collection of attachments without a documented assessment is difficult to defend and harder to maintain.",
        ],
        points: [
          "Quality agreement or documented purchasing requirements for critical solvents.",
          "Defined notification expectations for site, specification, method and package changes.",
          "Representative sample testing with approved acceptance criteria.",
          "Approval scope naming product, grade, site, packaging format and intended use.",
        ],
      },
      {
        heading: "Treat third-party documents as inputs, not approvals",
        paragraphs: [
          "EU GMP Annex 15 states that third-party qualification or validation documentation should be checked by appropriate site personnel for suitability and compliance with internal procedures before approval. The same principle is useful for solvent evidence. A supplier TDS or chromatogram can reduce uncertainty, but the regulated user decides whether it supports the intended method.",
          "Chapter 4 emphasises controlled documentation within the pharmaceutical quality system. Store the final assessment, raw comparison data, approval, restrictions and review date together. Make it clear which files are current controlled documents and which are historical evidence.",
        ],
      },
      {
        heading: "Maintain the supplier after approval",
        paragraphs: [
          "Ongoing review should combine batch-document accuracy, complaint and deviation history, delivery performance, changes, audit outcomes and laboratory trends. Define escalation thresholds: repeated COA corrections, unexplained retention-time shifts, damaged closures or late change notifications can justify targeted testing or temporary restriction even if no lot has formally failed.",
          "A supplier score should not replace scientific assessment. Use it to identify where review is needed, then document the technical decision and any revised controls.",
        ],
      },
    ],
    caseStudy: {
      label: "Qualification case framework",
      title: "A pharmaceutical site replaces a questionnaire-only approval",
      context: "An illustrative EU pharmaceutical site has approved chromatography-solvent suppliers using only procurement questionnaires. An inspection-readiness review finds no link between supplier approval and the methods using each solvent.",
      actions: [
        "The site inventories solvent uses and ranks methods by sensitivity and release impact.",
        "For critical solvents, it combines quality-system evidence with specification review and worst-case method testing.",
        "Approval records name the manufacturing site, grade and package actually assessed.",
        "Annual review is expanded to include deviations, COA accuracy, complaints, delivery and notified changes.",
      ],
      result: "The revised file shows why the supplier and product were approved, what the approval covers and which events trigger reassessment.",
    },
    checklist: [
      "Intended use and analytical risk documented",
      "Manufacturing and testing sites identified",
      "Specification, TDS, SDS and representative COA assessed",
      "Worst-case sample evaluation completed where required",
      "Approved product, grade, site and packaging scope recorded",
      "Change-notification expectations established",
      "Ongoing performance review combines quality and supply evidence",
      "Batch-specific COA verified for delivered material",
    ],
    sources: [
      { label: "European Commission - EU GMP Chapter 6 Quality Control", href: "https://health.ec.europa.eu/document/download/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf" },
      { label: "European Commission - EU GMP Chapter 4 Documentation", href: "https://health.ec.europa.eu/system/files/2016-11/chapter4_01-2011_en_0.pdf" },
      { label: "European Commission - EU GMP Annex 15", href: "https://health.ec.europa.eu/document/download/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf" },
      { label: "EMA - ICH Q14 analytical procedure development", href: "https://www.ema.europa.eu/en/ich-q14-analytical-procedure-development-scientific-guideline" },
    ],
    productLinks: [
      { label: "Browse Product Documents", href: "/downloads" },
      { label: "Request Technical Support", href: "/contact?type=information" },
    ],
  },
  {
    slug: "ready-to-use-hplc-mobile-phase-europe",
    title: "Ready-to-Use HPLC Mobile Phase in Europe: Reducing Preparation Variability",
    shortTitle: "Ready-to-Use HPLC Mobile Phase Europe",
    description: "A practical guide to qualifying ready-to-use HPLC mobile phase in Europe for consistent preparation, traceability, method transfer and regulated laboratory workflows.",
    primaryKeyword: "ready-to-use HPLC mobile phase Europe",
    tag: "Workflow Solutions",
    readingTime: "9 min technical guide",
    intro: "Pre-prepared mobile phase can remove repetitive weighing, mixing, pH adjustment, filtration and degassing from the laboratory, but convenience alone is not a qualification argument. The prepared solution must match the analytical procedure, remain stable in its package and carry enough traceability for the laboratory's quality system.",
    painPoints: [
      { title: "Analyst-to-analyst preparation drift", detail: "Small differences in weighing, pH adjustment, mixing order, filtration and degassing become retention-time or response variability." },
      { title: "Preparation records are incomplete", detail: "The final composition cannot be reconstructed when reagent lots, water source or pH adjustments are missing." },
      { title: "Large bags create hidden stability assumptions", detail: "A solution may be qualified unopened but remain connected to the instrument beyond its supported in-use period." },
      { title: "Method transfer stops at the instrument", detail: "Sites transfer the gradient and column but not the detailed mobile-phase preparation controls." },
    ],
    sections: [
      {
        heading: "Define the prepared solution as a controlled material",
        paragraphs: [
          "The specification should state composition, concentration or ratio, acceptable pH where relevant, water quality, filtration, bioburden or microbial-control expectations when relevant, packaging atmosphere, container, unopened shelf life and in-use conditions. The label and COA should allow the laboratory to connect the solution lot to every analytical sequence.",
          "EU GMP Chapter 6 expects laboratory reagents and solutions to be prepared and controlled by written procedures with controls commensurate to use and stability data. Outsourcing preparation changes who performs the work; it does not remove the laboratory's responsibility to define suitability and maintain records.",
        ],
      },
      {
        heading: "Qualify composition, package and connection practice together",
        paragraphs: [
          "Test the ready-to-use phase against the approved in-house preparation using the intended method. Compare system suitability, retention time, peak response, baseline, resolution and any method-specific critical attributes. Include at least one end-of-shelf-life or justified stability point when the application is sensitive to composition drift.",
          "The package is part of the system. Assess light exposure, gas permeability, closure or connector compatibility, dispensing orientation, headspace and the maximum time connected to the instrument. A 5 L or 20 L bag is valuable only when consumption and in-use controls prevent the open package from becoming the new source of variability.",
        ],
        points: [
          "Document the exact formulation and allowable preparation tolerance.",
          "Use the same column, method and system-suitability solution for the comparison.",
          "Challenge the intended package size and connection period.",
          "Define storage, equilibration and disposal instructions at the point of use.",
        ],
      },
      {
        heading: "Use ready-to-use phase to improve method transfer",
        paragraphs: [
          "During transfer between European sites or contract laboratories, mobile-phase preparation is often compressed into one line of the method. A qualified prepared solution can standardise a variable that otherwise depends on local water systems, balances, pH meters, filters and analyst technique.",
          "ICH Q14 frames analytical procedure development and maintenance around understanding, robustness and an analytical procedure control strategy. A prepared mobile phase can be part of that strategy when its critical attributes and lifecycle controls are defined, rather than treated as an unexamined convenience product.",
        ],
      },
      {
        heading: "Calculate value from avoided variation, not solvent price alone",
        paragraphs: [
          "Compare total preparation time, review time, consumables, rejected preparations, repeated system suitability, deviation investigations, storage and waste. High-throughput laboratories may gain most from released analyst capacity and consistent preparation records; low-frequency methods may gain less if opened packages cannot be consumed within a justified period.",
          "The decision should be method-specific. A standardised solution can reduce one source of variability, but it cannot correct an unsuitable column, unstable analyte, contaminated instrument or poorly controlled sample preparation.",
        ],
      },
    ],
    caseStudy: {
      label: "Workflow case framework",
      title: "A fermentation laboratory standardises dilute sulfuric acid mobile phase",
      context: "An illustrative European fermentation QC laboratory prepares 0.005N sulfuric acid daily for organic-acid analysis. Different analysts record small preparation differences and the team spends time reviewing retention shifts.",
      actions: [
        "The laboratory defines concentration, water quality, filtration, package and in-use requirements for a prepared solution.",
        "It compares in-house and ready-to-use lots using system suitability and representative fermentation samples.",
        "The chosen bag size is matched to weekly consumption and a maximum connected period.",
        "Lot number and opening time are captured directly in the analytical sequence record.",
      ],
      result: "The model removes daily preparation as a variable while preserving method suitability checks and traceability. It does not assume a universal stability period or guaranteed performance without site qualification.",
    },
    checklist: [
      "Composition and allowable tolerance match the analytical procedure",
      "Water, filtration and packaging requirements are specified",
      "In-house and ready-to-use phases compared with predefined criteria",
      "Package size matches consumption and justified in-use period",
      "Storage and connection practice included in the SOP",
      "Lot and opening information captured with each sequence",
      "Supplier change notification and stability data reviewed",
      "Total workflow cost assessed instead of price per litre alone",
    ],
    sources: [
      { label: "European Commission - EU GMP Chapter 6 Quality Control", href: "https://health.ec.europa.eu/document/download/c74c8720-27bf-4252-808f-d65a206a90bb_en?filename=2014-11_vol4_chapter_6.pdf" },
      { label: "EMA - ICH Q14 analytical procedure development", href: "https://www.ema.europa.eu/en/ich-q14-analytical-procedure-development-scientific-guideline" },
      { label: "EMA - ICH Q2(R2) analytical procedure validation", href: "https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline" },
      { label: "EDQM - Ph. Eur. chapter 2.2.46", href: "https://www.edqm.eu/en/w/general-chapter-2.2.46.-chromatographic-separation-techniques-now-published-in-ph.-eur.-11th-edition" },
    ],
    productLinks: [
      { label: "Browse Ready-to-Use Solutions", href: "/products/ready-to-use-solutions" },
      { label: "View 0.005N Sulfuric Acid Mobile Phase", href: "/products/acidified-mobile-phases/organic-acid-mobile-phase" },
    ],
  },
];

export function getEuropeHplcArticle(slug: string) {
  return EUROPE_HPLC_ARTICLES.find((article) => article.slug === slug);
}
